Citations

Mayo Clinic

Showing 10 of 108523 citations.

Shared Decision Making in Senior Medical Students
Zeballos‐Palacios, Claudia , Quispe, Renato, Mongilardi, Nicole, Diaz‐Arocutipa, Carlos , Mendez-Davalos, Carlos , Lizarraga, Natalia, Marchena, Aldo Paz- , Montori, Víctor M. , Málaga, Germán , Quispe, Renato , Montori, Victor M

Medical Decision Making | March 2, 2015 | Volume: 35 | Issue: 4 | Pages: 533-538

10.1177/0272989x15573746 | PMID 25732722 Get It

Purpose. To explore perceptions and experiences of Peruvian medical students about observed, preferred, and feasible decision-making approaches. Methods. We surveyed senior medical students from 19 teaching hospitals in 4 major cities in Peru. The self-administered questionnaire collected demographic information, current approach, exposure to role models for and training in shared decision making, and perceptions of the pertinence and feasibility of the different decision-making approaches in general as well as in challenging scenarios. Results. A total of 327 senior medical students (51% female) were included. The mean age was 25 years. Among all respondents, 2% reported receiving both theoretical and practical training in shared decision making. While 46% of students identified their current decision-making approach as clinician-as-perfect-agent, 50% of students identified their teachers with the paternalistic approach. Remarkably, 53% of students thought shared decision making should be the preferred approach and 50% considered it feasible in Peru. Among the 10 challenging scenarios, shared decision making reached a plurality (40%) in only one scenario (terminally ill patients). Conclusion. Despite limited exposure and training, Peruvian medical students aspire to practice shared decision making but their current attitude reflects the less participatory approaches they see role modeled by their teachers.
Heart rate is associated with progression of atrial fibrillation, independent of rhythm
Holmqvist, Fredrik , Kim, Sunghee , Steinberg, Benjamin A. , Reiffel, James A. , Mahaffey, Kenneth W. , Fonarow, Gregg C. , Chang, Paul, Kowey, Peter R. , Thomas, Laine , Piccini, Jonathan P. , Gersh, Bernard J. , Naccarelli, Gerald V. , Freeman, James V. , Peterson, Eric D. , Steinberg, Benjamin A

Heart | March 2, 2015 | Volume: 101 | Issue: 11 | Pages: 894-899

10.1136/heartjnl-2014-307043 | PMID 25732748 Get It

Objective Atrial fibrillation (AF) often progresses from paroxysmal or persistent to more sustained forms, but the rate and predictors of AF progression in clinical practice are not well described. Methods Using the Outcomes Registry for Better Informed Treatment of AF, we analysed the incidence and predictors of progression and tested the discrimination and calibration of the HATCH (hypertension, age, TIA/stroke, chronic obstructive pulmonary disease, heart failure) and CHA2DS2VASc scores for identifying AF progression. Results Among 6235 patients with paroxysmal or persistent AF at baseline, 1479 progressed, during follow-up (median 18 (IQR 12–24) months). These patients were older and had more comorbidities than patients who did not progress (CHADS2 2.3±1.3 vs 2.1±1.3, p<0.0001). At baseline, patients with AF progression were more often on a rate control as opposed to a rhythm control strategy (66 vs 56%, p<0.0001) and had higher heart rate (72(64–80) vs 68(60–76) bpm, p<0.0001). The strongest predictors of AF progression were AF on the baseline ECG (OR 2.30, 95% CI 1.95 to 2.73, p<0.0001) and increasing age (OR 1.16, 95% CI1.09 to 1.24, p<0.0001, per 10 increase), while patients with lower heart rate (OR 0.84, 95% CI 0.79 to 0.89, p<0.0001, per 10 decrease ≤80) were less likely to progress. There was no significant interaction between rhythm on baseline ECG and heart rate (p=0.71). The HATCH and CHA2DS2VASc scores had modest discriminatory power for AF progression (C-indices 0.55 (95% CI 0.53 to 0.58) and 0.55 (95% CI 0.52 to 0.57)). Conclusions Within 1.5 years, almost a quarter of the patients with paroxysmal or persistent AF progress to a more sustained form. Progression is strongly associated with heart rate, and age.
Adolescent With Lymphadenopathy in the Absence of Systemic Symptoms
Bidadi, Behzad, Uzodi, Adaora S. , Pritt, Bobbi S. , Khan, Shakila P. , Henry, Nancy K., Pritt, Bobbi S

Clinical Pediatrics | March 2, 2015 | Volume: 54 | Issue: 12 | Pages: 1221-1223

10.1177/0009922815574082 | PMID 25733674 Get It

Endomyocardial biopsy-integrating electrode at the bioptome tip
Konečný, Tomáš , Cooper, Leslie T. , Mulpuru, Siva K. , Sandhu, Gurpreet S. , Asirvatham, Samuel J. , Kapa, Suraj , Noseworthy, Peter A. , Asirvatham, Samuel J , Cooper, Leslie T

Therapeutic Advances in Cardiovascular Disease | March 2, 2015 | Volume: 9 | Issue: 3 | Pages: 66-69

10.1177/1753944715574660 | PMID 25731185 Get It

Background: The addition of electroanatomic mapping to a standard echo-guided endomyocardial biopsy could identify areas of abnormal pathology and increase the diagnostic yield of the procedure. Methods and results: In this demonstration of a novel technique, a 45-year-old woman with clinical suspicion for cardiac sarcoidosis underwent right ventricular bipolar electroanatomical mapping with identification of areas of signal fractionation and low voltage. A bioptome, configured to record an electrogram from the tip, was then visualized on the three-dimensional electroanatomic mapping (3DEAM) system, and directed to these areas. The biopsy was assisted by the use of a steerable introducer sheath, and by recording unipolar and extended bipolar signals from the bioptome tip. A prominent change in the signal was detected by the electrode at the bioptome tip when the jaws closed on the endomyocardial tissue. Patient tolerated the procedure without complications, and the biopsied samples were appropriate for pathological analysis. Conclusions: Using existing technology, the 3DEAM, which integrates unipolar and bipolar signal from the bioptome tip, is feasible, and can be safely added to a standard echocardiographically guided endomyocardial biopsy. Future studies should investigate whether such a technique could increase the safety and diagnostic yield of endomyocardial biopsies in patients with suspected cardiomyopathies.
Faculty Opinions recommendation of A next-generation dual-recombinase system for time- and host-specific targeting of pancreatic cancer.
Fernández-Zapico, Martín E. , Iguchi, Eriko

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature | March 2, 2015 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.3410/f.723062915.793504382 Get It

Faculty Opinions recommendation of Vitamin D receptor-mediated stromal reprogramming suppresses pancreatitis and enhances pancreatic cancer therapy.
Fernández-Zapico, Martín E. , Iguchi, Eriko

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature | March 2, 2015 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.3410/f.718889697.793504383 Get It

Re‐induction chemoimmunotherapy with epratuzumab in relapsed acute lymphoblastic leukemia (ALL): Phase II results from Children's Oncology Group (COG) study ADVL04P2
Raetz, Elizabeth A. , Cairo, Mitchell S. , Borowitz, Michael J., Lu, Xiaomin , Goldenberg, David M. , Wegener, William A., Zeng, Hui , Whitlock, James A. , Adamson, Peter C. , Carroll, William L. , Reid, Joel M. , Devidas, Meenakshi , Hunger, Stephen P.

Pediatric Blood & Cancer | March 2, 2015 | Volume: 62 | Issue: 7 | Pages: 1171-1175

10.1002/pbc.25454 | PMID 25732247 Get It

BackgroundGiven the success of immunotherapeutic approaches in hematologic malignancies, the COG designed a phase I/II study to determine whether the addition of epratuzumab (anti‐CD22) to an established chemotherapy platform improves rates of second remission (CR2) in pediatric patients with B‐lymphoblastic leukemia (B‐ALL) and early bone marrow relapse.ProcedureTherapy consisted of three established blocks of re‐induction chemotherapy. Epratuzumab (360 mg/m2/dose) was combined with chemotherapy on weekly × 4 (B1) and twice weekly × 4 [eight doses] (B2) schedules during the first re‐induction block. Remission rates and minimal residual disease (MRD) status were compared to historical rates observed with the identical chemotherapy platform alone.ResultsCR2 was achieved in 65 and 66%, of the evaluable B1 (n = 54) and B2 patients (n = 60), respectively; unchanged from that observed historically without epratuzumab. Rates of MRD negativity (<0.01%) were 31% in B1 (P = 0.4128) and 39% in B2 patients (P = 0.1731), compared to 25% in historical controls. The addition of epratuzumab was well tolerated, with a similar toxicity profile to that observed with the re‐induction chemotherapy platform regimen alone.ConclusionsEpratuzumab was well tolerated in combination with re‐induction chemotherapy. While CR2 rates were not improved compared to historical controls treated with chemotherapy alone, there was a non‐significant trend towards improvement in MRD response with the addition of epratuzumab (twice weekly for eight doses) to re‐induction chemotherapy. Pediatr Blood Cancer 2015;62:1171–1175. © 2015 Wiley Periodicals, Inc.
Tricuspid Annular Plane Systolic Excursion and Its Association with Mortality in Critically Ill Patients
Gajanana, Deepakraj, Rammohan, Harish Seetha, Alli, Oluseun , Romero‐Corral, Abel, Purushottam, Bhaskar, Ponamgi, Shiva , Figueredo, Vincent M. , Pressman, Gregg S.

Echocardiography | March 2, 2015 | Volume: 32 | Issue: 8 | Pages: 1222-1227

10.1111/echo.12926 | PMID 25728401 Get It

BackgroundTransient left ventricular dysfunction can occur under conditions of extreme emotional or physiological stress. There is little data on right ventricular function in such situations.MethodsOne hundred twenty patients admitted to an ICU with a noncardiac illness were studied. Those with documented coronary disease, ejection fraction <40%, sepsis, or intracranial hemorrhage were excluded. Echocardiograms were performed within 24 hours of admission. Tricuspid annular plane systolic excursion (TAPSE) was measured to assess right ventricular systolic function. Plasma catecholamines (norepinephrine, epinephrine, dopamine) were measured on admission. Clinical and demographic data were collected, along with data on ICU length of stay (LOS), hospital LOS, and in‐hospital and long‐term mortality. TAPSE was tested for correlation with adverse outcomes and length of stay.ResultsMean TAPSE for the group was 2.05 ± 0.66 cm. Based on area under the ROC curve analysis, TAPSE <2.4 cm was the best cutoff for predicting in‐hospital and long‐term mortality. There were 13 in‐hospital deaths, 12 in the group with TAPSE <2.4 cm and one among those with TAPSE ≥2.4 cm. On multivariate analysis, TAPSE <2.4 cm was a significant predictor of in‐hospital mortality (χ2 = 4.6, P = 0.03). When tested against hospital LOS, an inverse correlation was found (P = 0.04). No association was found between TAPSE and catecholamine levels.ConclusionsRight ventricular systolic function, as assessed by TAPSE, has important prognostic value in critically ill patients. Mean values were lower in patients who died in‐hospital versus those who survived to discharge. In addition, patients with TAPSE <2.4 cm had a longer hospital length of stay.
Life at the Extreme: Physiological Adaptation
Sieck, Gary C. , Sieck, Gary

Physiology | March 1, 2015 | Volume: 30 | Issue: 2 | Pages: 84-85

10.1152/physiol.00001.2015 | PMID 25729053 Get It